학술논문
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Document Type
Artikel
Author
Chemaly, RF; Dadwal, SS; Bergeron, A; Ljungman, P; Kim, YJ; Cheng, GS; Pipavath, SN; Limaye, AP; Blanchard, E; Winston, DJ; Stiff, PJ; Zuckerman, T; Lachance, S; Rahav, G; Small, CB; Mullane, KM; Patron, RL; Lee, DG; Hirsch, HH; Waghmare, A; McKevitt, M; Jordan, R; Guo, Y; German, P; Porter, DP; Gossage, DL; Watkins, TR; Marty, FM; Chien, JW; Boeckh, M
Source
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71(11):2777-2786
Subject
Language
English
English
English
ISSN
1537-6591